As presented by Dr. Robert Cameron at the 11th International Conference of the International Mesothelioma Interest Group (iMig) Boston, MA – September 11-14, 2012
Sarcomatoid-predominant malignant pleural mesothelioma is an especially difficult tumor to control. Thoracic surgeons at UCLA seeking to improve the poor prognosis that comes with this incredibly aggressive cancer looked at the treatment of non-mesothelioma pleural sarcomas, which is typically treated with chemotherapy followed by surgery and radiation.
Doctors identified four patients with sarcomatoid-predominant malignant pleural mesothelioma who had received pre-operative therapy before undergoing the lung-sparing pleurectomy/decortication procedure. Three of these patients utilized Ifosfamide/Adriamycin and one patient Cisplatin/Pemetrexed/ Veglin. Three-fourths of these patients were found to have pathological responses with 80-99% necrosis, or tumor death, which is not often seen with standard Cisplatin and Pemetrexed.
Multimodality approaches that utilize Ifosfamide/Adriamycin seem to be the optimal treatment strategy for sarcomatoid-predominant malignant pleural mesothelioma patients. In addition, patients who originally are not eligible for surgery may become so if they see 80% or higher necrosis and remain free of metastatic growth following chemotherapy. Click here to view this abstract.
Related Posts :
Los Angeles Jury Awards More Than $5.55 Million to 70 Year Old Navy VeteranLos Angeles Jury Awards More Than $5.55 Million to 70 Year Old Navy Veteran and Pump Mechanic Exposed to Dust From Asbestos Gaskets and Pack… Read More...
International Panel of Medical Specialists Convene for First-Ever Medical Symposium Dedicated to Lung-Sparing Therapies for Patients With Malignant Pleural MesotheliomaThe UCLA Mesothelioma Research Program, in conjunction with the Pacific Meso Center, held the 1st International Symposium on Lung-Sparing Th… Read More...
Meso Empowerment Exclusive: Dr. Cameron shares his brilliant insights on breakthrough moments at IMIG Conference in Boston or, Galileo is SmilingDr. Robert CameroniMig 2012Dr. Robert Cameron, thoracic surgeon and mesothelioma specialist, was kind enough to provide us with his tweets a… Read More...
Percutaneous Outpatient Cryoablation for Localized Recurrent Pleural Mesothelioma Following Lung-sparing Pleurectomy and Decortication SurgeryAs presented by Dr. Robert Cameron at the 11th International Conference of the International Mesothelioma Interest Group (iMig) Boston,… Read More...
Honoring our Duty to Treat Veterans with Late Onset War-Related Diseases, Worthingtons donate $100,000 to the Pacific Meso CenterLOS ANGELES. As we celebrate the end of the war in Iraq, in which nearly 4,500 US soldiers were killed in action, and over 30,000 were injur… Read More...